Equity Bancshares

EQBK · NYSE

$47.94+$0.71 (+1.50%)TodayMarket closed ·
Prev close $47.23

EQBK analyst rating

HoldConsensus of 7 analysts over the last 12 months. 43% rate it a buy.
  • Strong buy0
  • Buy3
  • Hold4
  • Underperform0
  • Sell0

12-month price target · 9 analysts

Average $57.56 (+20.1% upside)

Low
$51.51
Now
$47.94
High
$63.00

Upgrades and downgrades

The latest rating actions, newest first

EQBK analyst upgrades, downgrades and rating actions
FirmDateActionRating
Piper SandlerOct 16, 2026MaintainsNeutral
Stephens & Co.Oct 16, 2026MaintainsOverweight
StoneXOct 16, 2026MaintainsBuy
Piper SandlerOct 2, 2026DowngradeOverweight → Neutral
Piper SandlerSep 8, 2026MaintainsOverweight
DA DavidsonSep 4, 2026MaintainsNeutral
StoneXSep 4, 2026MaintainsBuy
Stephens & Co.Jul 16, 2026MaintainsOverweight
BenchmarkJun 25, 2026InitiatesBuy
DA DavidsonJun 22, 2026MaintainsNeutral

The case for and against

Updated Oct 14, 2026

Bull case

Equity Bancshares is well positioned by a disciplined adjacent-market acquisition strategy that has expanded its footprint into Iowa while preserving a low-risk rural-plus-metro model across Arkansas, Kansas, Missouri, Oklahoma, and now Iowa. Management’s expectation that the Lincoln Savings Bank deal can generate 5.1% EPS accretion in 2027 and 7.5% in 2028, alongside 30% expense savings and only 3.8% tangible book value dilution, supports a constructive fundamental view despite some near-term NIM and ROA pressure. Record quarter-to-date loan production, lower expected runoff than prior deals, and continued buybacks of 150,000-175,000 shares per quarter suggest improving organic growth and capital efficiency as pro forma assets move toward the $10B threshold.

Bear case

Equity Bancshares is facing a challenging setup because its earnings depend heavily on net interest margin, core deposit growth, and fee income, all of which could soften if loan growth slows or the operating environment weakens. The company also carries meaningful execution risk from acquisitions, where poor integration or regulatory friction could weigh on profitability and delay expected benefits, while elevated operating expenses may further pressure returns. On top of that, a decline in credit quality, a significant economic deterioration in the Midwest or Central U.S., and a more aggressive Fed rate path could damage asset quality, balance sheet growth, and valuation sentiment.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.